Dihydrotestosterone inhibits insulin-stimulated cyclin D2 messenger ribonucleic acid expression in rat ovarian granulosa cells by reducing the phosphorylation of insulin receptor substrate-1

Endocrinology

Volumn 147, Issue 1, 2006, Pages 464-471

  Kayampilly, Pradeep P ^a   Menon, K M J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; CYCLIN D2; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RAF PROTEIN; RNA;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXPOSURE; FEMALE; GENE EXPRESSION; GRANULOSA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STIMULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CYCLINS; DIHYDROTESTOSTERONE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GRANULOSA CELLS; INSULIN; PHOSPHOPROTEINS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 29344439384     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-0818     Document Type: Article

References (41)

1. Peters H 1978 Folliculogenesis in mammals. In: Jones RE, ed. The vertebrate ovary. New York: Plenum Press; 121-144
2. Hirshfield AN 1991 Development of follicles in the mammalian ovary. Int Rev Cytol 124:43-101
3. Zeleznik AJ 2004 The physiology of follicle selection. Reprod Biol Endocrinol 2:31
4. Barnes R, Rosenfield RL 1989 The polycystic ovary syndrome: pathogenesis and treatment. Ann Intern Med 110:386-399
5. Barbieri RL 1991 Polycystic ovarian disease. Annu Rev Med 42:199-204
6. Azziz R 2003 Androgen excess is the key element in polycystic ovary syndrome. Fertil Steril 80:252-258
7. Ehrmann DA, Barnes RB, Rosenfield RL 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322-351
8. Erickson GF, Yen SSC 1984 New data on follicle cells in polycystic ovaries: a proposed mechanism for the genesis of cystic follicles. Semin Reprod Endocrinol 42:39-43
9. Stewart PM, Shackleton CHL, Beastall GH, Edwards CRW 1990 5α-reductase activity in polycystic ovary syndrome. Lancet 335:431-433
10. Jakimiuk A, Weitsman S, Magoffin D 1999 The 5α-reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 84:2414-2418
11. Sherr CJ, Roberts JM 1995 Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163
12. Xiong Y, Zhang H, Beach D 1992 D-type cyclins associate with multiple protein kinases and DNA replication and repair factor PCNA. Cell 71:505-514
13. Sherr CJ 1993 Mammalian G1 cyclins. Cell 73:1059-1065
14. 27kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitotic signals. Cell 78:59-66
15. 27kip1 for restriction point control of fibroblast cell cycle. Science 272:877-880
16. Pradeep PK, Li X, Peegel H, Menon KMJ 2002 Dihydrotestosterone inhibits granulosa cell proliferation by decreasing the cyclin D2 mRNA expression and cell cycle arrest at G1 phase. Endocrinology 143:2930-2935
17. Kayampilly PP, Menon KMJ 2004 Inhibition of extracellular signal-regulated protein kinase-2 phosphorylation by dihydrotestosterone reduces follicle stimulating hormone mediated cyclin D2 messenger ribonucleic acid expression in rat granulosa cells. Endocrinology 145:1786-1793
18. WuXK, Sallinen K, Anttila L, Makinen M, Luo C, Pollanen P, Erkkola R 2003 Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from control. Fertil Steril 74:564-572
19. Roy SK, Terada DM 1999 Activities of glucose metabolic enzymes in human preantral follicles: in vitro modulation by follicle stimulating hormone, luteinizing hormone, epidermal growth factor, insulin like growth factor-I and transforming growth factor βI. Biol Reprod 60:763-768
20. Willis D, Frank S 1995 Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab 80:3788-3790
21. Willis D, Mason H, Gilling-Smith C, Frank S 1996 Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 81:302-309
22. White MF 1997 The insulin signaling system and IRS proteins. Diabetologica 40:S2-S17
23. White MF 2003 Insulin signaling pathway. Sci. STKE (Connections Map) (http://stke.sciencemag.org/cgi/cm/stkecm;cmp_6880)
24. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Mary YP, Robker RL, Richards JS, McGinnis LK, Biggers JD, John JE, Bronson RT, Elledge SJ, Weinberg RA 1996 Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470-474
25. Sanders MM, Midgley Jr AJ 1982 Rat granulosa cell differentiation: an in vitro model. Endocrinology 111:614-624
26. Campbell KL 1979 Ovarian granulosa cells isolated with EGTA and hypertonic sucrose: cellular integrity and function. Bio Reprod 21:773-786
27. El-Hefnawy T, Zeleznik AJ 2001 Synergism between FSH and activin in the regulation of proliferating cell nuclear antigen and cyclin D2 expression in undifferentiated rat granulosa cells. Endocrinology 142:4357-4362
28. Channing CP, Schaerf FW, Anderson LD, Tsafrri A 1980 Ovarian follicular and luteal physiology. Int Rev Physiol 22:117-201
29. Savion N, Lui GM, Laherty R, Gospodarowicz D 1981 Factors controlling proliferation and progesterone production by bovine granulosa cells in serum free medium. Endocrinology 109:409-420
30. Davoren JB, Hsueh AJ 1984 Insulin enhances FSH-stimulated steroidogenesis by cultured rat granulosa cells. Mol Cell Endocrinol 35:97-105
31. Jia XC, Hsueh AJ 1985 Sensitive in vitro bioassay for the measurement of serum follicle-stimulating hormone. Neuroendocrinology 41:445-448
32. Nobels F, Dewailly D 1992 Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis. Fertil Steril 58:655-666
33. Phy LP, Conover CA, Abbott DH, Zschunke MA, Walker DL, Session DR, Tummon IS, Thornhill AR, Lesnick TG, Dumesic DA 2004 Insulin and messenger ribonucleic acid expression of insulin receptor isoforms in ovarian follicles from nonhirsute ovulatory women and polycystic ovary syndrome patients. J Clin Endocrinol Metab 89:3561-3566
34. Park Y, Maizels ET, Feiger ZJ, Alam H, Peters CA, Woodruff TK, Unterman TG, Lee EJ, Jameson L, Hunzicker-Dunn M 2005 Induction of cyclin D2 in rat granulosa cells requires FSH-dependent relief from FOXO1 repression coupled with positive signals from Smad. J Biol Chem 280:9135-9148
35. Salteil AR 1996 Diverse signalling pathways in the cellular actions of insulin. Am J Physiol 270:375-385
36. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S 1994 Insulin resistance and growth retardation in mice lacking insulin receptor substarte-1. Nature 372:182-186
37. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren J, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF 1998 Distribution of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904
38. Chong H, Lee J, Guan K 2001 Positive and negative regulation of Raf-1 kinase activity and function by phosphorylation. EMBO J 20:3716-3727
39. Brubaker PL, Drucker DJ 2004 Glucagon-like peptides regulates cell proliferation and apoptosis in the pancreas, gut and central nervous system. Endocrinology 145:2653-2659
40. Menu E, Kooijman R, Van Valckenorgh E, Asosingh K, Bakkus M, Van Camp B, Vanderkerken K 2004 Specific roles for the PI3 K and MEK-ERK pathway in IGF-1 stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model. Br J Cancer 90:1076-1083
41. Nelson-Degrave VL, Wickenheisser JK, Hendricks KL, Asano T, Fujishiro M, Legro RS, Kimmball SR, Strauss III JF, McAllister JM 2004 Alterations in MEK and ERK signalling in thecal cells contribute to excessive androgen production in polycystic ovary syndrome (PCOS). Mol Endocrinol 19:379-390